Pay in 4 interest-free payments of $5.54 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Im just saying, lets be careful in select patients because I think theres the potential to do harm. You found hypotension was most common among patients over 65 and those with diabetes
It is well-known as a glucagon-like peptide-1 receptor agonist ( GLP-1 RA ), which mimics the GLP-1 hormone the human body produces after a meal, causing the pancreas to release more insulin
About Semaglutide Semaglutide is a GLP-1 receptor agonist that may be considered in clinician-supervised weight-management programs
A phase 2 trial of semaglutide 2.4 mg in 71 cirrhotic patients confirmed an acceptable safety profile without significant decompensation events, although the primary histological endpoint was not met, possibly due to the limited ability of antifibrotic remodeling to achieve biopsy-detectable fibrosis stage improvement in established cirrhosis over 48 weeks [46]
The peptide demonstrates regional selectivity in its fat-reducing effects, showing particular efficacy in reducing visceral adipose tissue (deep abdominal fat) and subcutaneous fat deposits
